ArticleCritical care explorations2023

Annexin A5 in Patients With Severe COVID-19 Disease: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Feasibility Trial.

Claudio M Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.